Guardant Health, Inc. - Common Stock (GH)

About Guardant Health, Inc. - Common Stock (GH)

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Details

Daily high

$51.50

Daily low

$49.49

Price at open

$50.74

52 Week High

$53.42

52 Week Low

$20.14

Market cap

6.4B

Dividend yield

0.00%

Volume

1.2M

Avg. volume

2.1M

P/E ratio

-15.18

Guardant Health, Inc. - Common Stock News